Risk of hemorrhagic and ischemic stroke for combined antiplatelet therapy and new generation oral anticoagulants in patients with acute coronary syndrome: Meta-analysis of 11 randomized clinical trial
第一作者机构：[1]Capital Univ Med Sci, Beijing Heart Lung & Blood Vessel, Beijing Anzhen Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Gao F.,Zhou Y. J.,Wang Z. J.,et al.Risk of hemorrhagic and ischemic stroke for combined antiplatelet therapy and new generation oral anticoagulants in patients with acute coronary syndrome: Meta-analysis of 11 randomized clinical trial[J].EUROPEAN HEART JOURNAL.2015,36:327-327.
APA：
Gao, F.,Zhou, Y. J.,Wang, Z. J.,Shen, H.,Yang, S. W.&Liu, X. L..(2015).Risk of hemorrhagic and ischemic stroke for combined antiplatelet therapy and new generation oral anticoagulants in patients with acute coronary syndrome: Meta-analysis of 11 randomized clinical trial.EUROPEAN HEART JOURNAL,36,
MLA：
Gao, F.,et al."Risk of hemorrhagic and ischemic stroke for combined antiplatelet therapy and new generation oral anticoagulants in patients with acute coronary syndrome: Meta-analysis of 11 randomized clinical trial".EUROPEAN HEART JOURNAL 36.(2015):327-327
医学